Medulloblastoma Molecular Subgroup and Hyperfractionated Radiation Therapy Alone for Standard Risk Medulloblastoma : Results of the Pool Data of MSFOP 1998 and 2007 Studies

Results of pooled data from MSFOP 98 and MSFOP 2007 studies testing hyperfractionated radiotherapy without chemotherapy in standard risk medulloblastoma on 114 evaluable patients and correlation with the new biomolecular classification in 93/114 cases. Between 12/98 and 10/01, 48 patients were included in the MSFOP 98 trial and between 10/08 and 07/13, 66 patients were included in the MSFOP 2007 observational study with the same treatment and...